Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-04-01
1977-11-29
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260254, 260256, A61K 3152, C07D47308
Patent
active
040606171
ABSTRACT:
A compound of the formula ##STR1## wherein R is hydrogen or methyl, n is a number from 1 to 4 and `Acyl` is nicotinoyl, 3-methylpyrazole-5-carboyl, 3-methyl-isoxazolyl-5-carboyl, 5-n-butylpyridin-2-carboyl, 2-(4-chlorophenoxy)-2-methyl-propionyl, 2-acetoxybenzoyl or theophyllinyl-7-acetyl, are useful for their effect on serum lipoids and, in particular, for treating adverse hyperlipidemic states in humans.
REFERENCES:
patent: 2756229 (1956-07-01), Stoll
patent: 2878251 (1959-03-01), Zirm et al.
patent: 3935196 (1976-01-01), Higuchi et al.
patent: 3984413 (1976-10-01), Metz et al.
Brenner Gunter
Credner Karl
Geisel Berthold
Tauscher Manfred
Coughlan, Jr. Paul M.
Wulfing Johann A.
LandOfFree
Esters of the ophyllinylacetic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esters of the ophyllinylacetic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esters of the ophyllinylacetic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1633827